Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial
Published Online: 2021-06-?
Journal: The Lancet Haematology•Publisher: Elsevier BV
Authors: Anas Younes•Andrea Gallamini•David J Straus•Ewa Lech-Maranda•Hun Ju Lee•Jan Walewski•Javier Munoz•John Radford•Joseph M Connors•Keenan Fenton•Kerry J Savage•Marco Picardi•Martin Hutchings•Meredith Little•Michelle Fanale•Monika Długosz-Danecka•Nancy L Bartlett•Pier Luigi Zinzani•Piotr Smolewski•Rachael Liu•Radhakrishnan Ramchandren•Ranjana Advani•Sergey Alekseev•Stephen M Ansell•Tatyana Feldman•Won Seog Kim•Árpád Illés
